35th Hemophilia Symposium : Hamburg 2004

35th Hemophilia Symposium Hamburg 2004

Motion analysis as introduced 2 years ago on a national basis effectively identifies individual functional disorders and provides a means for describing them on the basis of a score. Individual therapy planning is possible. More treatment tends to produce better function scores and thus helps to low...

Descripción completa

Detalles Bibliográficos
Autor Corporativo: SpringerLink (-)
Otros Autores: Scharrer, Inge (-), Schramm, Wolfgang
Formato: Libro electrónico
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg 2006.
Colección:Springer eBooks.
Acceso en línea:Conectar con la versión electrónica
Ver en Universidad de Navarra:https://innopac.unav.es/record=b32884990*spi
Tabla de Contenidos:
  • Epidemiology
  • HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2003/2004 Survey)
  • Hemophilia Registry of the Medical Committee of the Swiss Hemophilia Association {u2014} Update and Annual Survey 2004
  • Risk of Infections and Inhibitors in Hemophilia
  • Update on the Safety of Clotting Factors, Mainly Regarding the Risk of Transmission of vCJD (Variant Creutzfeldt Jakob Disease)
  • nvCJD and Blood Products in the UK
  • Mutation Type Dependent Inhibitor Risk {u2014} a Single Center Study on 432 Patients with Severe Hemophilia A
  • Inhibitor Incidence in Previously Untreated Patients (PUPs) with Hemophilia A and B. A Prospective Multi-Center Study of the Pediatric Committee of the German, Swiss and Austrian Society for Thrombosis and Hemostasis Research (GTH)
  • ADVATE Inhibitor Risk Profile: 18 Months post-Licensure
  • EACH-Registry: An European Registry for Acquired Hemophilia
  • Elective Orthopedic Surgery for Hemophilia Patients with Inhibitors
  • Chronic Synovitis and Long-term Results of Orthopedic Treatment
  • Results after Total Knee and Hip Replacement in Patients with Hemophilia A {u2014} A Single Center Experience
  • Motion Analysis Epidemiology in Hemophilic Children
  • Radiosynoviorthesis in Hemophilic Arthropathy {u2014} A Single Center Experience
  • Laboratory Diagnostics: Coagulation Factor, Inhibitors, Monitoring
  • Individual Therapy of Hemophilia {u2014} New Laboratory Methods Considering Platelets
  • Epitope Mapping during FVIII Inhibitor Elimination with Rituximab Reveals Conformational Epitopes on FVIII and Identifies Small Molecules Blocking Inhibitor and Targeting B Cells
  • Lack of Factor VIII Expression Represents a Novel Mechanism Leading to Hemophilia A
  • Pediatric Hemostaseology
  • Effects of the Factor V G1691 A Mutation and the Factor II G20210A Variant on the Clinical Expression of Severe Hemophilia A (< 2%) in Children {u2014} Results of a Multicenter Study
  • Continuous Infusion of Factor Concentrates in Children with Hemophilia A in Comparison to Bolus Injections
  • Decreased Clotting Factor Activity (VIII, IX, XI, and XII) due to Inhibitors with Lupus-like Activity in Childhood
  • Free Lectures
  • Effect of Activated Recombinant Coagulation Factor VII on the Function of Glycoprotein IIb/IIIa-Inhibited Platelets in Vitro
  • Mutation Analysis in Hereditary Angioedema Identifies Patients at Risk for Developing Acute and Life Threatening Edema
  • Recurrent Mutation in ADAMTS13 Gene as a Cause of a Hereditary Thrombotic Thrombocytopenic Purpura in the Czech Republic
  • Clinical Manifestations of Patients with Dysfibrinogenemia
  • Case Report of a FXIII Inhibitor in a 77-year-old Patient
  • Poster
  • The ABC{u2019}s of Hemophilia
  • The Long Journey to Being Diagnosed as a Carrier of Hemophilia A {u2014} A Woman with Abnormally Prolonged Bleeding after Myocardial Infarction
  • Clinical Investigation of Orthopedic Outcome in Patients with Severe Hemophilia {u2014} Advantage of an Early Prophylactic Treatment?
  • The Relevance of Thrombophilic Risk Factors on Bleeding Tendency in Hemophilia A Patients
  • Magnetic Field Therapy in Patients with Severe Hemophilia {u2014} Motion Analysis and Quality Control
  • The Clinical Course of two Patients Receiving High Dose Factor VIII {u2014} Replacement Therapy
  • Determination of the Factor VIII Plasma Activity of Hemophilia A Patients Treated with a New Recombinant Factor VIII Concentrate
  • Socio-Economic Aspects of Hemophilia Treatment in Romania
  • Immunosuppressive Treatment in Acquired von-Willebrand{u2019}s Syndrome
  • HCV-Infection in HIV-Infected and Non-Infected People with Hemophilia {u2014} A Retrospective Study: Medical Aspects
  • HCV-Infection in HIV-Infected and Non-Infected People with Hemophilia {u2014} A Retrospective Study: Psychosocial Aspects
  • Testing Factor VIII Activity by Using the Chromogenic Assay in Carriers of Hemophilia A
  • Hip Replacement in Hemophilic Patients {u2014} A 30 Years Single Center Experience
  • Successful Therapy with anti CD20 Monoclonal Antibody Rituximab in Patients with Acquired Hemophilia against Factor VIII
  • Unusual Prolonged Course of an Immune Tolerance Therapy (ITT) in a Patient with Severe Hemophilia A and a High-Titer Inhibitor Development
  • Successful Major Surgery with Minimal Dosage of rFVIIa in a Hemophilia A Patient with High Level of Alloantibodies to Factor VIII
  • Inhibitor Development after Continuous Infusion of Factor VIII: A Retrospective Study in Germany
  • Inhibitors in PTP{u2019}S: A Retrospective Study in Germany
  • Elective Orthopedic Surgery in Inhibitor Patients {u2014} the Frankfurt Concept
  • The Frequency of Venous Thromboembolism in Women with FV Leiden in Association with Pregnancy and Puerperium
  • Spectrum of Molecular Defects and Mutation Detection Date in Patients with Severe Hemophilia A
  • Hemophilia Patients and Prothrombotic Gene Mutation
  • ?A1a82Gly Represents a Common Fibrinogen Chain Variant in Caucasians
  • A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 Gene (VKORC1) Causes Increased Phenprocoumon Requirement
  • Denaturing High Performance Liquid Chromatography Represents an Efficient Technique for Detection of Heterozygous Large Deletions in Antithrombin Gene
  • Recurrent Coronary Stent Thrombosis in a Patient with Combined Aspirin and Clopidogrel Resistance
  • Coagulation Factor XIII Mutation Profile: Update 2004
  • Site-Directed Mutagenesis of VKORC1, the Target Protein of Coumarin-Type Anticoagulants
  • Treatment of Dilution Coagulopathy by Fibrinogen and Platelet Concentrates
  • Pathogenesis of Hepatic Veno-Occlusive Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Ejemplares similares